1. Statement by Alexander M. Schmidt, Commissioner, U.S. Food and Drug Administration before the U.S. Senate Joint Hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary. Preclinical and Clinical Testing by the Pharmaceutical Industry. Part 3, No. Y4.L11/2:P49/2/976/pt.3, CIS# S541-12. 1976; 3-56.
2. Creative Penmanship in Animal Testing Prompts FDA Controls
3. The Murky World of Toxicity Testing